Literature DB >> 33606973

CRISPR base editor screens identify variant function at scale.

Phoebe C R Parrish1, Alice H Berger2.   

Abstract

Cuella-Martin et al. (2021) and Hanna et al. (2021) showcase CRISPR base editing in large-scale pooled screens in human cells to discover both loss- and gain-of-function variants, enabling protein structure/function insights and clinical variant interpretation.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33606973      PMCID: PMC9017793          DOI: 10.1016/j.molcel.2021.01.036

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   19.328


  10 in total

1.  High-throughput Phenotyping of Lung Cancer Somatic Mutations.

Authors:  Alice H Berger; Angela N Brooks; Xiaoyun Wu; Yashaswi Shrestha; Candace Chouinard; Federica Piccioni; Mukta Bagul; Atanas Kamburov; Marcin Imielinski; Larson Hogstrom; Cong Zhu; Xiaoping Yang; Sasha Pantel; Ryo Sakai; Jacqueline Watson; Nathan Kaplan; Joshua D Campbell; Shantanu Singh; David E Root; Rajiv Narayan; Ted Natoli; David L Lahr; Itay Tirosh; Pablo Tamayo; Gad Getz; Bang Wong; John Doench; Aravind Subramanian; Todd R Golub; Matthew Meyerson; Jesse S Boehm
Journal:  Cancer Cell       Date:  2016-07-28       Impact factor: 31.743

2.  Perturbing proteomes at single residue resolution using base editing.

Authors:  Philippe C Després; Alexandre K Dubé; Motoaki Seki; Nozomu Yachie; Christian R Landry
Journal:  Nat Commun       Date:  2020-04-20       Impact factor: 14.919

3.  Massively parallel assessment of human variants with base editor screens.

Authors:  Ruth E Hanna; Mudra Hegde; Christian R Fagre; Peter C DeWeirdt; Annabel K Sangree; Zsofia Szegletes; Audrey Griffith; Marissa N Feeley; Kendall R Sanson; Yossef Baidi; Luke W Koblan; David R Liu; James T Neal; John G Doench
Journal:  Cell       Date:  2021-02-18       Impact factor: 41.582

4.  Functional interrogation of DNA damage response variants with base editing screens.

Authors:  Raquel Cuella-Martin; Samuel B Hayward; Xiao Fan; Xiao Chen; Jen-Wei Huang; Angelo Taglialatela; Giuseppe Leuzzi; Junfei Zhao; Raul Rabadan; Chao Lu; Yufeng Shen; Alberto Ciccia
Journal:  Cell       Date:  2021-02-18       Impact factor: 41.582

5.  Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage.

Authors:  Nicole M Gaudelli; Alexis C Komor; Holly A Rees; Michael S Packer; Ahmed H Badran; David I Bryson; David R Liu
Journal:  Nature       Date:  2017-10-25       Impact factor: 49.962

6.  Multiplex assessment of protein variant abundance by massively parallel sequencing.

Authors:  Kenneth A Matreyek; Lea M Starita; Jason J Stephany; Beth Martin; Melissa A Chiasson; Vanessa E Gray; Martin Kircher; Arineh Khechaduri; Jennifer N Dines; Ronald J Hause; Smita Bhatia; William E Evans; Mary V Relling; Wenjian Yang; Jay Shendure; Douglas M Fowler
Journal:  Nat Genet       Date:  2018-05-21       Impact factor: 38.330

7.  A CRISPR-based base-editing screen for the functional assessment of BRCA1 variants.

Authors:  Jiyeon Kweon; An-Hee Jang; Ha Rim Shin; Ji-Eun See; Woochang Lee; Jong Won Lee; Suhwan Chang; Kyunggon Kim; Yongsub Kim
Journal:  Oncogene       Date:  2019-08-29       Impact factor: 9.867

8.  Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.

Authors:  Alexis C Komor; Yongjoo B Kim; Michael S Packer; John A Zuris; David R Liu
Journal:  Nature       Date:  2016-04-20       Impact factor: 49.962

9.  Accurate classification of BRCA1 variants with saturation genome editing.

Authors:  Gregory M Findlay; Riza M Daza; Beth Martin; Melissa D Zhang; Anh P Leith; Molly Gasperini; Joseph D Janizek; Xingfan Huang; Lea M Starita; Jay Shendure
Journal:  Nature       Date:  2018-09-12       Impact factor: 49.962

10.  Single-cell analysis of a mutant library generated using CRISPR-guided deaminase in human melanoma cells.

Authors:  Soyeong Jun; Hyeonseob Lim; Honggu Chun; Ji Hyun Lee; Duhee Bang
Journal:  Commun Biol       Date:  2020-04-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.